Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01314651 · ClinicalTrials.gov registry record · NA

Efficacy of Behavioral Insomnia Treatment for Chronic Migraine

A NA study of Insomnia and Chronic Migraine, sponsored by Daniel Riche.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT01314651 is a NA study of Insomnia and Chronic Migraine that has completed, run by Daniel Riche. The registered enrollment target is 31 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01314651, a NA study of Insomnia and Chronic Migraine, has completed, sponsored by Daniel Riche.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the efficacy of a brief behavioral insomnia intervention in reducing headache frequency and severity among patients with chronic migraine and insomnia. It is hypothesized that this intervention will produce greater changes in headache frequency and severity than will a comparison treatment involving non-sleep-specific general lifestyle modifications.

Interventions

  • BEHAVIORAL Lifestyle Modification
  • BEHAVIORAL Stimulus Control and Sleep Restriction

Study Locations (1)

Mississippi

  • Psychological Services Center - University

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2011-03
Est. Completion 2013-12
Phase NA

Sponsor

Daniel Riche

1 total trials

What the Registry Record Tells You About NCT01314651

The ClinicalTrials.gov registry entry for NCT01314651 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower). The listed sponsor is Daniel Riche, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Modification is the first listed.

NCT01314651 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.

Frequently Asked Questions

What is clinical trial NCT01314651 about?

NCT01314651 is a clinical study titled "Efficacy of Behavioral Insomnia Treatment for Chronic Migraine". The purpose of this study is to test the efficacy of a brief behavioral insomnia intervention in reducing headache frequency and severity among patients with chronic migraine and insomnia. It is hypothesized that this intervention will produce greater changes in headache frequency and severity than ...

What is the current status of trial NCT01314651?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2011-03. Estimated completion is 2013-12.

What conditions does trial NCT01314651 study?

This clinical trial studies the following conditions: Insomnia, Chronic Migraine.

What interventions are being tested in trial NCT01314651?

The interventions under investigation include: Lifestyle Modification (BEHAVIORAL), Stimulus Control and Sleep Restriction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01314651?

This trial is sponsored by Daniel Riche, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01314651 being conducted?

This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.